Please login to the form below

Not currently logged in
Email:
Password:

Menarini

This page shows the latest Menarini news and features for those working in and with pharma, biotech and healthcare.

The IMC unites health industry professionals to combat antibiotic resistant infections

The IMC unites health industry professionals to combat antibiotic resistant infections

the British Society for Antimicrobial Chemotherapy (BSAC), Menarini UK, Pfizer UK, Roche Diagnostics UK, Thermo Fisher Scientific and the UK Sepsis Trust.

Latest news

  • New cancer meds and drug extensions top CHMP recommendations New cancer meds and drug extensions top CHMP recommendations

    This includes Adenuric, blockbuster oncology treatment Avastin (bevacizumab) from Roche; AbbVie's auto-inflammatory drug Humira (adalimumab), Menarini's gout drug Adenuric, (febuxostat), the rare disease drug for kidney disease Soliris

  • Campaigns recognised at German health comms awards Campaigns recognised at German health comms awards

    Among the winners was Schmittgall, which picked up two awards, including the disease awareness prize for its TheraKey project for Berlin Chemie, a subsidiary of Italy's Menarini.

  • Menarini launches urology campaign in Greece Menarini launches urology campaign in Greece

    PE information push includes Not Just A Moment website. Menarini is supporting a new awareness initiative to educate men about premature ejaculation.

  • Developing your patient-centric strategy Developing your patient-centric strategy

    AbbVie. 4. Menarini. 5. Janssen. Source: PatientView. Nevertheless, it's worth revisiting the announcement of ViiV's birth four and a half years ago.

  • Five companies breach ABPI code Five companies breach ABPI code

    Lundbeck, A Menarini Pharma, Bayer, HRA Pharma UK and GlaxoSmithKline named by PMCPA. ... Lundbeck, A Menarini Pharma, Bayer, HRA Pharma UK and GlaxoSmithKline (GSK) were named by the PMCPA – the Code's administrator - in medical, pharmaceutical and

More from news
Approximately 4 fully matching, plus 23 partially matching documents found.

Latest Intelligence

  • Pharma deals in April 2015 Pharma deals in April 2015

    Dr Reddy's, Menarini and Cipher Pharmaceuticals have acquired or licensed rights to products in South Asia, Asia Pacific (ex-Japan) and North America and Mexico, respectively. ... Menarini AP will be responsible for the clinical development, regulatory

  • Medius Deal Watch table for April 2015 Medius Deal Watch table for April 2015

    120. 4SC AG/Menarini. Licensing and development agreement. Resminostat (oral HDAC) for hepatocellular carcinoma.

  • Deal Watch table for July 2013 Deal Watch table for July 2013

    130‡. Vivus / Berlin-Chemie  (Menarini). Licence, commercialisation, supply. Spedra (avanafil) for erectile dysfunction (approved).

  • Pharma investment in Indonesia Pharma investment in Indonesia

    Two years prior to its acquisition by the Italian Menarini group in Dec 2012, the Invida Group acquired 70 per cent stake of Indonesian pharmaceutical manufacturer MUGI.

  • Pharma deals during October 2012 Pharma deals during October 2012

    Whilst Oxford BioTherapeutics will be responsible for the discovery activities, Menarini will lead on the manufacture and clinical development of each programme. ... Whilst no financial terms have been disclosed, a quotation from Menarini states that the

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • Frontera Group Frontera Group

    Medskin Solutions . Menarini Farmaceutica Internazionale . Merck. Merz Pharmaceuticals. Mitsubishi Pharma Europe.

  • Life wins at the Rx Club Show

    Menarini. Life also picked up 6 awards of excellence in the print category for Life self-promotion and for clients Galderma and Abbott.

More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Graphite Digital

We’re a digital CX agency collaborating with healthcare and pharmaceutical organisations to help them connect more deeply with their audiences...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....